Atlas Trials

Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality

Clinical trial NCT07743047 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07743047
Sponsor
IRCCS San Raffaele
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2026-09-01
Primary completion
2028-12-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.